PYY3-36 as an anti-obesity drug target.
Boggiano MM, Chandler PC, Oswald KD, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Schindler M, Arndt K, Rudolf K, Mark M, Schoelch C, Joost HG, Klaus S, Thöne-Reineke C, Benoit SC, Seeley RJ, Beck-Sickinger AG, Koglin N, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Deng XY, Whitcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Ortmann S, Castañeda TR, Tschöp M.
Boggiano MM, et al. Among authors: schoelch c.
Obes Rev. 2005 Nov;6(4):307-22. doi: 10.1111/j.1467-789X.2005.00218.x.
Obes Rev. 2005.
PMID: 16246216
Review.